Observational studyMedicine2019

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks: A retrospective observational study.

Yafei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.